ERBB2 and gastric cancer: Its prognostic value was even better than those of the classic pathologic factors such as TNM stage and differentiation of tissue, which suggested that the expression of ERBB2d16 might be a novel factor to predict the prognosis of patients with HER2-positive gastric cancer.